Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems

This study has been completed.
Sponsor:
Collaborators:
Cumberland Pharmaceuticals
Norton Healthcare
Information provided by (Responsible Party):
University of Louisville
ClinicalTrials.gov Identifier:
NCT00889538
First received: April 28, 2009
Last updated: December 6, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)